$WYGC
Longwen Group Corp. Stock $wygc

$wygc Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000101738623000204 Filed on May 12, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q4
Revenue	$1.204M	$240.7K	$21.83K
YoY Change	17579.98%	20455.85%
Cost Of Revenue	$1.087M	$201.4K
YoY Change
Gross Profit	$116.4K	$39.35K
YoY Change	1609.94%	3260.72%
Gross Profit Margin	9.67%	16.35%
Selling, General & Admin	$127.4K	$83.91K	$571.7K
YoY Change	74.39%	761.45%
% of Gross Profit	109.45%	213.21%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.222K	$3.305K	$3.100K
YoY Change	463.29%	2211.19%
% of Gross Profit	2.77%	8.4%
Operating Expenses	$236.5K	$657.1K	$571.7K
YoY Change	-297.68%	1375.88%
Operating Profit	-$121.5K	-$618.2K
YoY Change	7.5%	1329.47%
Interest Expense		-$60.00	-$130.00
YoY Change		-148.0%
% of Operating Profit
Other Income/Expense, Net	-$186.00	-$490.00	$80.00
YoY Change
Pretax Income		-$618.3K	-$549.9K
YoY Change
Income Tax	$2.415K	$843.00	$0.00
% Of Pretax Income
Net Earnings	-$123.9K	-$619.1K	-$549.9K
YoY Change	9.64%	1331.42%
Net Earnings / Revenue	-10.29%	-257.19%	-2518.83%
Basic Earnings Per Share	$0.00	-$0.01
Diluted Earnings Per Share	$0.00	-$0.01	-$0.01
COMMON SHARES
Basic Shares Outstanding	79.11M shares	79.11M shares	69.53M shares
Diluted Shares Outstanding	79.20M shares	78.01M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments		$20.80K	$68.12K
YoY Change
Cash & Equivalents	$8.539K	$20.80K	$68.12K
Short-Term Investments
Other Short-Term Assets		$23.87K	$58.41K
YoY Change
Inventory	$39.57K	$41.78K
Prepaid Expenses	$53.66K	$23.87K	$58.41K
Receivables		$226.6K
Other Receivables		$0.00
Total Short-Term Assets	$555.9K	$313.1K	$126.5K
YoY Change	440.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$255.1K	$272.4K	$274.4K
YoY Change	3584.01%
Goodwill	$1.132K	$1.132K	$1.132K
YoY Change	14.0%
Intangibles	$3.103K	$3.458K	$3.625K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$259.3K	$277.0K	$279.1K
YoY Change	3175.43%
TOTAL ASSETS
Total Short-Term Assets	$555.9K	$313.1K	$126.5K
Total Long-Term Assets	$259.3K	$277.0K	$279.1K
Total Assets	$815.2K	$590.1K	$405.7K
YoY Change	636.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$436.5K	$212.5K	$31.96K
YoY Change			2358.62%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt		$224.1K	$102.7K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$651.8K	$436.6K	$134.7K
YoY Change	609.33%		894.14%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$651.8K	$436.6K	$134.7K
Total Long-Term Liabilities		$0.00	$0.00
Total Liabilities	$651.8K	$436.6K	$134.7K
YoY Change	609.33%		894.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.77M	-$19.65M	-$19.03M
YoY Change	7.23%		4.08%
Common Stock	$7.983K	$7.911K	$7.411K
YoY Change	21.38%		13.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$163.4K	$153.5K	$271.0K
YoY Change
Total Liabilities & Shareholders Equity	$815.2K	$590.1K	$405.7K
YoY Change	636.44%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q4
OPERATING ACTIVITIES
Net Income	-$123.9K	-$619.1K	-$549.9K
YoY Change	9.64%	1331.42%
Depreciation, Depletion And Amortization	$3.222K	$3.305K	$3.100K
YoY Change	463.29%	2211.19%
Cash From Operating Activities		-$167.7K	-$66.05K
YoY Change		115.7%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	-$220.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00	-$3.530K
YoY Change
Cash From Investing Activities			-$3.300K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$119.9K	-150.5K
YoY Change		-39.52%
NET CHANGE
Cash From Operating Activities		-$167.7K	-66.05K
Cash From Investing Activities			-3.300K
Cash From Financing Activities		$119.9K	-150.5K
Net Change In Cash		-$47.32K	-219.9K
YoY Change		-141.32%
FREE CASH FLOW
Cash From Operating Activities		-$167.7K	-$66.05K
Capital Expenditures		$0.00	-$220.00
Free Cash Flow		-$167.7K	-$65.83K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	lwlw	Online Product Sales OnlineProductSales		usd
CY2022Q1	lwlw	Aquaculture Product Sales Net AquacultureProductSalesNet		usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000723533
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	lwlw	Online Product Sales Expenses OnlineProductSalesExpenses		usd
CY2022Q1	lwlw	Acquaculture Product Sales Expenses AcquacultureProductSalesExpenses		usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation		usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets		usd
CY2023Q1	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		usd
CY2022Q1	us-gaap	Proceeds From Loans ProceedsFromLoans		usd
CY2022Q1	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q1	us-gaap	Acquisition Costs AcquisitionCosts		usd
CY2022Q1	us-gaap	Notes Reduction NotesReduction		usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q1	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome		usd
CY2022Q1	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome		usd
CY2023Q1	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-11596
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	LONGWEN GROUP CORP.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-3506403
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	No. 25
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Caihe Rd
CY2023Q1	dei	Entity Address Address Line3 EntityAddressAddressLine3	Shangcheng Dist.
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Hangzhou
CY2023Q1	dei	Entity Address Country EntityAddressCountry	CN
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	310000
CY2023Q1	dei	City Area Code CityAreaCode	+86 0571
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	85128985
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	79108925	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20798	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	68121	usd
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	226608	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	41783	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	23874	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	58413	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	313063	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	126534	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	272442	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	274370	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3458	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3625	usd
CY2023Q1	us-gaap	Goodwill Goodwill	1132	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1132	usd
CY2023Q1	us-gaap	Assets Assets	590095	usd
CY2022Q4	us-gaap	Assets Assets	405661	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	212525	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	31962	usd
CY2023Q1	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	133963	usd
CY2022Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	12250	usd
CY2023Q1	us-gaap	Loans Payable Current LoansPayableCurrent	90128	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	90494	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	436616	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	134706	usd
CY2023Q1	us-gaap	Liabilities Liabilities	436616	usd
CY2022Q4	us-gaap	Liabilities Liabilities	134706	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79108926	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79108926	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	74108926	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	74108926	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	7911	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7411	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19785039	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19285539	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19646924	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19027835	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	7453	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5840	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	153479	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	270955	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	590095	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	405661	usd
CY2023Q1	lwlw	Consulting Service Income ConsultingServiceIncome	13026	usd
CY2022Q1	lwlw	Consulting Service Income ConsultingServiceIncome	1171	usd
CY2023Q1	lwlw	Online Product Sales OnlineProductSales	6082	usd
CY2023Q1	lwlw	Aquaculture Product Sales Net AquacultureProductSalesNet	221601	usd
CY2023Q1	us-gaap	Revenues Revenues	240709	usd
CY2022Q1	us-gaap	Revenues Revenues	1171	usd
CY2023Q1	lwlw	Online Product Sales Expenses OnlineProductSalesExpenses	2199	usd
CY2023Q1	lwlw	Acquaculture Product Sales Expenses AcquacultureProductSalesExpenses	199156	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	201355	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	39354	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	1171	usd
CY2023Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	73155	usd
CY2022Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	34780	usd
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	500000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	83905	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9740	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	657060	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	44520	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-617706	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-43349	usd
CY2023Q1	lwlw	Interest Expense1 InterestExpense1	-55	usd
CY2022Q1	lwlw	Interest Expense1 InterestExpense1	-125	usd
CY2023Q1	us-gaap	Other Income OtherIncome	-485	usd
CY2022Q1	us-gaap	Other Income OtherIncome	224	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-540	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	99	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-618246	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-43250	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	843	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-619089	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-43250	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	1613	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	482	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	1613	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	482	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-617476	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-42768	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78010025	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65173317	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-619089	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-43250	usd
CY2023Q1	us-gaap	Depreciation Depreciation	3305	usd
CY2022Q1	us-gaap	Depreciation Depreciation	143	usd
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	500000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	227486	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	41945	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-34613	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	34750	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	182937	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	125	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-167665	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-77732	usd
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	5412	usd
CY2022Q1	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	7	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5405	usd
CY2022Q1	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	82107	usd
CY2023Q1	us-gaap	Proceeds From Loans ProceedsFromLoans	134481	usd
CY2023Q1	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	14618	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	116087	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	119863	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	198194	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	479	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-518	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-47323	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	114539	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68121	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20798	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	114539	usd
CY2022Q1	us-gaap	Acquisition Costs AcquisitionCosts	993	usd
CY2023Q1	us-gaap	Notes Reduction NotesReduction	14050	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	270955	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	500000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1613	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-619089	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	153479	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-13550	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	116087	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	482	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-43250	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	59769	usd
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 750
	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	127061	shares
	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1	66667	shares
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1	65000000	shares
CY2022Q1	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	1000	usd
CY2022Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	993	usd
CY2022Q4	us-gaap	Acquisition Costs AcquisitionCosts	1000
CY2022Q4	us-gaap	Acquisition Costs AcquisitionCosts	141	usd
CY2022Q4	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	139	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zm46q3uFgcn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Use of Estimates</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Actual results may differ from those estimates and assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zfrz8cDTgQb6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0"><span style="text-decoration: underline">Concentration </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0">During the three months ended March 31, 2023, the Company generated 63% and 20% of revenues from the top 2 customers, respectively. The Company’s cost of revenues consisted of 65%, 21% and 13% purchases from top 3 vendors, respectively, for the three months ended March 31, 2023. The Company’s revenue and cost of revenues were not material during the three months ended March 31, 2022.</p>
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-619089	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19646924	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7450	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7419	usd
CY2023Q1	us-gaap	Land Land	272489	usd
CY2022Q4	us-gaap	Land Land	271319	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7497	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4368	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	272442	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	274370	usd
	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	2651780	shares
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	265178	usd
CY2023Q1	lwlw	Value Added Tax Payable ValueAddedTaxPayable	2108	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	263070	usd
CY2023Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	3122	usd
CY2022Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	143	usd
CY2023Q1	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	133963	usd
CY2022Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	12250	usd
CY2019Q4	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	300	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	125	usd
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	19100000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	19000000.0	usd
CY2023Q1	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	760807	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	630975	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	760807	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	630975	usd
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-129832	usd
CY2022Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-9083	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	630975	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	474226	usd
CY2023Q1	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense	760807	usd
CY2022Q1	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense	483309	usd
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79108926	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79108926	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	74108926	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	74108926	shares
CY2023Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.30
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4250000	shares
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	425000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5000000	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	500000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	750000	shares
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	82107	usd
CY2023Q1	us-gaap	Payments For Loans PaymentsForLoans	14618	usd
CY2023Q1	us-gaap	Payments For Loans PaymentsForLoans	100000
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	14050	usd
CY2023Q1	us-gaap	Capital Lease Obligations CapitalLeaseObligations	33737	usd
CY2023Q1	us-gaap	Contractual Obligation ContractualObligation	50000000
CY2023Q1	us-gaap	Contractual Obligation ContractualObligation	7300000	usd

Files In Submission

Name	View Source	Status
0001017386-23-000204-index-headers.html	Edgar Link	pending
0001017386-23-000204-index.html	Edgar Link	pending
0001017386-23-000204.txt	Edgar Link	pending
0001017386-23-000204-xbrl.zip	Edgar Link	pending
exhibit_31-1.htm	Edgar Link	pending
exhibit_31-2.htm	Edgar Link	pending
exhibit_32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lwlw-20230331.xsd	Edgar Link	pending
lwlw_2023mar31-10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
lwlw-20230331_def.xml	Edgar Link	unprocessable
lwlw-20230331_cal.xml	Edgar Link	unprocessable
lwlw-20230331_pre.xml	Edgar Link	unprocessable
lwlw_2023mar31-10q_htm.xml	Edgar Link	completed
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
lwlw-20230331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WYGC
Longwen Group Corp. Stock $wygc

2023 Q2 Form 10-Q Financial Statement

#000101738623000204 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WYGC Longwen Group Corp. Stock $wygc

2023 Q2 Form 10-Q Financial Statement

#000101738623000204 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WYGC
Longwen Group Corp. Stock $wygc